01 12-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO)
02 1HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY
03 1PSEUDOMONAS EXOTOXIN (RECOMBINANT, NLYSPE38) CONJUGATED MURINE MAB (B3) TO B3 ANTIGEN AND RITUXIMAB [CHIMERIC MOAB (C2B8) (IDEC) TO CD20]
01 3NATIONAL INSTITUTES HEALTH NATIONAL CANCER INSTITUTE
01 3U.S.A
01 3Inactive
01 3Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18615
Submission : 1993-03-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18728
Submission : 2005-09-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17814
Submission : 2004-10-25
Status : Inactive
Type : II
National Cancer Institute is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Bevacizumab+Rituximab bulk offered by National Cancer Institute
Find a price of HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY bulk offered by National Cancer Institute
Find a price of 2-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO) bulk offered by National Cancer Institute
LOOKING FOR A SUPPLIER?